Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

November 24, 2020

Fight CRC’s EAO Work Featured in USA Today

Author(s):

Fight CRC

On November 24, 2020, USA Today included Mediaplanet’s Digestive Health insert, featuring an article authored by Andrea (Andi) Dwyer, advisor to Fight CRC’s Patient Education and Research Team. Through The USA Today, targeted distribution and vast online/social media outlets, this publication, both in print and online, reached an estimated 20 million readers.

Titled Colorectal Cancer Doesn’t Discriminate by Age, the article included Fight CRC’s recommendations from our early-age onset research blueprint. “In June 2020, more than 400 researchers, scientists, and patient or research advocates worldwide joined together virtually to develop pathways based on a 2019 published research blueprint designed to better study causation of early-age onset CRC. The types of questions and risk factors to be studied include diet in childhood; obesity at certain times in life; microbiome within the colon; antibiotic use in childhood; and gene and environment interactions.”

Fight CRC takes our role in the path to a cure seriously. We hope this feature will bring light to the critical-nature of EAO CRC and forge research in the right direction, saving lives along the way.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Eng.
Image of man with black hair.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Image of woman with blonde hair.
Image of Dr. Fakih.
Image of Doctor with blonde hair.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Scott Kopetz
Image of woman with black hair.
Related Content
Advertisement
Some patients with advanced colorectal cancer responded to leronlimab: © stock.adobe.com.
July 1st 2025

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

Spencer Feldman
Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.
Teri Greige with medals
February 16th 2023

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Tecentriq/chemo combo reduces the risk of death vs chemo alone in dMMR, stage 3 CRC: © stock.adobe.com.
June 1st 2025

Tecentriq Plus Chemo Reduced Risk of Death vs Chemo Alone in dMMR Colon Cancer

Tony Berberabe
Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Image of intestines.
May 20th 2025

Acoustic Cluster Therapy Shows Benefit in Colorectal Liver Metastases

Spencer Feldman
Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial.
Georgia Hurst is a fierce patient advocate for those with Lynch syndrome. Catch up on all of Georgia's blogs here!
May 19th 2025

Reflecting on my Son's Graduation as a Previvor

Georgia Hurst
As a Lynch syndrome previvor, I feel deep gratitude to witness my son’s graduation — a milestone my brother never lived to see with his own child.
Related Content
Advertisement
Some patients with advanced colorectal cancer responded to leronlimab: © stock.adobe.com.
July 1st 2025

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

Spencer Feldman
Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.
Teri Greige with medals
February 16th 2023

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Tecentriq/chemo combo reduces the risk of death vs chemo alone in dMMR, stage 3 CRC: © stock.adobe.com.
June 1st 2025

Tecentriq Plus Chemo Reduced Risk of Death vs Chemo Alone in dMMR Colon Cancer

Tony Berberabe
Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Image of intestines.
May 20th 2025

Acoustic Cluster Therapy Shows Benefit in Colorectal Liver Metastases

Spencer Feldman
Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial.
Georgia Hurst is a fierce patient advocate for those with Lynch syndrome. Catch up on all of Georgia's blogs here!
May 19th 2025

Reflecting on my Son's Graduation as a Previvor

Georgia Hurst
As a Lynch syndrome previvor, I feel deep gratitude to witness my son’s graduation — a milestone my brother never lived to see with his own child.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.